UBS Group’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2K | Buy |
3,755
+2,979
| +384% | +$17.6K | ﹤0.01% | 7057 |
|
|
2025
Q1 | $4.52K | Buy |
+776
| New | +$4.52K | ﹤0.01% | 7780 |
|
|
2024
Q3 | – | Sell |
-2,361
| Closed | -$19.8K | – | 8656 |
|
|
2024
Q2 | $19.8K | Buy |
2,361
+1,716
| +266% | +$14.4K | ﹤0.01% | 6161 |
|
|
2024
Q1 | $5.5K | Buy |
+645
| New | +$5.5K | ﹤0.01% | 6360 |
|
|
2023
Q1 | – | Sell |
-2,066
| Closed | -$22.5K | – | 8897 |
|
|
2022
Q4 | $22.5K | Sell |
2,066
-3,878
| -65% | -$42.2K | ﹤0.01% | 6360 |
|
|
2022
Q3 | $24K | Buy |
5,944
+5,739
| +2,800% | +$23.2K | ﹤0.01% | 6063 |
|
|
2022
Q2 | $1K | Buy |
+205
| New | +$1K | ﹤0.01% | 8888 |
|
|
2022
Q1 | – | Sell |
-1,428
| Closed | -$16K | – | 9507 |
|
|
2021
Q4 | $16K | Buy |
+1,428
| New | +$16K | ﹤0.01% | 7054 |
|
|
2021
Q2 | – | Sell |
-300
| Closed | -$6K | – | 8511 |
|
|
2021
Q1 | $6K | Sell |
300
-2,000
| -87% | -$40K | ﹤0.01% | 7209 |
|
|
2020
Q4 | $47K | Sell |
2,300
-492
| -18% | -$10.1K | ﹤0.01% | 5251 |
|
|
2020
Q3 | $49K | Buy |
2,792
+322
| +13% | +$5.65K | ﹤0.01% | 4816 |
|
|
2020
Q2 | $42K | Sell |
2,470
-1,075
| -30% | -$18.3K | ﹤0.01% | 5172 |
|
|
2020
Q1 | $34K | Buy |
3,545
+2,845
| +406% | +$27.3K | ﹤0.01% | 5229 |
|
|
2019
Q4 | $8K | Buy |
+700
| New | +$8K | ﹤0.01% | 6318 |
|